Dark

AZN
Astrazeneca plc - ADR
stock NASDAQ ADR

At Close

1/10/2025 3:59:58 PM EST

67.00USD+0.631%(+0.42)5,621,532

0.00Bid 0.00Ask 0.00Spread

Pre-market

1/10/2025 9:28:30 AM EST

67.17USD+0.886%(+0.59)13,012

After-hours

1/10/2025 4:30:30 PM EST

66.71USD-0.433%(-0.29)23,789

OverviewOptionsHistoricalExchangesShortsNews

Jan 24, 2022

02:17PM EST Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments? Benzinga

12:44PM EST Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows Benzinga

09:26AM EST Ionis' Eplontersen Receives FDA Orphan Drug Status For Misfolded Protein Disorder Benzinga

07:58AM EST From Oxford: Third Booster Of Either AstraZeneca, Pfizer, Janssen Or Sinovac COVID Shot Induce Higher Antibodies In Those Who Previously Got Two Sinovac Doses Benzinga

07:19AM EST Ionis' Eplontersen Receives Orphan Drug Designation from the FDA Benzinga

07:18AM EST AstraZeneca' Eplontersen Granted Orphan Drug Designation In US For Transthyretin Amyloidosis RTTNews

07:10AM EST Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis Business Wire

Jan 21, 2022

08:41AM EST Lower COVID-19 Vaccine Sales Estimated Amid Less Severe Omicron Variant: Bloomberg Benzinga

Jan 19, 2022

12:50PM EST AstraZeneca Rolls Out "Unprecedented' Three Year Survival Data For Imfinzi/Treme Combo In Liver Cancer Benzinga

04:54AM EST AstraZeneca Announced MFINZI (durvalumab) Plus Tremelimumab Demonstrated Unprecedented Survival in 1st-line Unresectable Liver Cancer With 31% of Patients Alive at Three Years Benzinga

04:53AM EST AstraZeneca Announced IMFINZI Plus Chemotherapy Reduced Risk of Death by 20% in 1st-Line Advanced Biliary Tract Cancer Benzinga

Jan 18, 2022

05:50PM EST IMFINZI(r) (durvalumab) Plus Tremelimumab Demonstrated Unprecedented Survival in 1st-line Unresectable Liver Cancer With 31% of Patients Alive at Three Years Business Wire

05:20PM EST IMFINZI(r) (durvalumab) Plus Chemotherapy Reduced Risk of Death by 20% in 1st-Line Advanced Biliary Tract Cancer Business Wire

Jan 17, 2022

07:41PM EST CORRECTING and REPLACING ENHERTU(r) granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen Business Wire

07:00AM EST Enhertu Granted Priority Review in the US for Patients With HER2-Positive Metastatic Breast Cancer Treated With a Prior Anti-HER2-Based Regimen Business Wire

02:13AM EST AstraZeneca: Enhertu Granted Priority Review In The US For Patients With HER2-positive Metastatic Breast Cancer RTTNews

Jan 16, 2022

04:38PM EST The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week Benzinga

Jan 13, 2022

02:30PM EST Supreme Court Blocks President Biden's Workplace Vaccine-Or-Test Mandate For Larger Employers; Grants Administration Request To Enforce Vaccine Mandate For Healthcare Workers Nationwide Benzinga

11:47AM EST The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact Benzinga

11:45AM EST Amgen And AstraZeneca Announce Availability Of TEZSPIRE For Shipment To Wholesalers In US Benzinga

11:45AM EST AstraZeneca Sells Additional Half-Million Doses Of Its COVID-19 Antibody To US Benzinga

11:45AM EST AstraZeneca's COVID-19 Vaccine Booster Against Omicron, Delta - New Data Supports Use Benzinga

11:45AM EST Scorpion Therapeutics Enters Agreement With AstraZeneca To Discover, Develop And Commercialize Novel Cancer Treatments Against 'Undruggable' Targets; Scorpion Will Receive An Upfront Cash Payment Of $75M And Is Eligible To Receive Up To An Additional $1.5 Benzinga

11:45AM EST Astrazeneca And Amgen Today Announced TEZSPIRE Is Now Available For Shipment To Wholesalers In The U.S. Benzinga

11:43AM EST Scorpion Therapeutics, AstraZeneca Ink Precision Medicines Pact For Hard-To-Target Cancer Proteins Benzinga

11:43AM EST AstraZeneca Announced New data from ongoing Trial of Vaxzevria Showed Increased Antibody Response Against Beta, Delta, Alpha, Gamma, Omicron Variants Following Third Dose Booster Benzinga

11:43AM EST AstraZeneca Announced it Aims to Redefine Liver, Biliary Tract and Prostate Cancer Treatment with Imfinzi and Lynparza Data to be Presented at ASCO Genitourinary Cancers Symposium Benzinga

11:43AM EST AstraZeneca and Scorpion Therapeutics Enter Agreement to Discover, Develop and Commercialize Novel Cancer Treatments Against Undruggable Targets; Scorpion to Receive an Upfront Cash Payment of $75M, Plus Potential Milestone Payments, Royalties Benzinga

07:12AM EST AstraZeneca To Present New Data In Liver, Biliary Tract And Prostate Cancers At ASCO GI And GU RTTNews

07:05AM EST AstraZeneca Aims to Redefine Liver, Biliary Tract and Prostate Cancer Treatment With Practice-Changing IMFINZI(r) (durvalumab) and LYNPARZA(r) (olaparib) Data at ASCO GI and GU Business Wire

07:00AM EST TEZSPIRE Now Available in the United States for the Treatment of Severe Asthma Business Wire

Jan 11, 2022

10:25AM EST EU Drug Regulator Says Should Be Careful In Not Overloading Immune System With Repeated COVID-19 Immunization Benzinga

08:36AM EST The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In Benzinga

Jan 10, 2022

04:33PM EST Fusion Pharmaceuticals Announces Nomination Of First Targeted Alpha Therapy Candidate In Collaboration With AstraZeneca To Advance Into IND-Enabling Studies For Phase 1 Development Benzinga

04:30PM EST Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development PR Newswire

Jan 7, 2022

01:01PM EST AstraZeneca Unit Alexion, Neurimmune Signed Exclusive Global Collaboration and License Agreement to Develop and Commercialize NI006 Benzinga

Jan 6, 2022

01:54PM EST White House Says Vaccine Mandates Related To Schools Are Always Up To School Districts Benzinga

Jan 5, 2022

04:55AM EST AstraZeneca Announced Transfer of Global Rights to Eklira, Duaklir Completed; AstraZeneca Received a Payment of $270M from Covis Pharma. Benzinga

Jan 4, 2022

11:06PM EST Cannabis Movers & Shakers: Aurora Bolsters Management, Curaleaf Names New Pres, Verano & Avicanna's New Appointments Benzinga

09:37AM EST CDC Recommends Pfizer Booster At 5 Months, Additional Primary Dose For Certain Immunocompromised Children Benzinga

04:27AM EST Shanghai Junshi Biosciences Scraps Agreement With AstraZeneca On Medicine Toripalimab Injection Benzinga

04:25AM EST Australia's Therapeutic Goods Administration Granted Provisional Determination to AstraZeneca for Covid-19 Prophylaxis and Treatment, Tixagevimab and Cilgavimab; Now Includes Prevention and Treatment of Covid-19 in Individuals Aged 12 Years and Older Benzinga

Jan 3, 2022

07:26AM EST Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact Benzinga

06:36AM EST Ovid Therapeutics Pays AstraZeneca $5M Cash and 7.5M Shares of Stock for a Library of Early-Stage Small Molecules Targeting the KCC2 Transporter Benzinga

Jan 2, 2022

03:30PM EST The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week Benzinga

Dec 31, 2021

05:23AM EST India's Serum Institute Applied to India's Drug Regulator and Health Ministry for Full Approval of Covishield Vaccine Under License from AstraZeneca Benzinga

Dec 30, 2021

11:47AM EST 'F.D.A. Is Said to Be Near Allowing Boosters for 12- to 15-Year-Olds' -New York Times Report Benzinga

Dec 27, 2021

01:28PM EST China Comes Out In Support of Continued U.S. Listings With Stronger Oversight Benzinga

Dec 23, 2021

12:20PM EST Oxford Lab Study Suggests AstraZeneca's COVID-19 Booster Works Against Omicron Benzinga

08:09AM EST AstraZeneca Partner Daiichi Sankyo Reports First Patient Dosed In DESTINY-Lung04 Phase 3 Trial Evaluating ENHERTU Benzinga

07:05AM EST AstraZeneca' EVUSHELD Antibody Combination Retains Neutralizing Activity Against Omicron Variant In Studies From Oxford RTTNews

07:00AM EST EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities Business Wire

05:56AM EST U.S. Equity Futures Higher Ahead of Christmas Weekend; Positive News on Effectiveness of Vaccines Against Omicron Variant Benzinga

05:17AM EST AstraZeneca Announced Evusheld Long-acting Antibody Combination Retains Neutralising Activity Against Omicron Variant in Studies From Oxford and Washington Universities Benzinga

Dec 22, 2021

03:26PM EST 'In @WHCOVIDResponse briefing, Zients gives update on supply in what he calls the nation's medicine cabinet for #covid19. In Jan.: 265K courses of Pfizer drug, 3M of Merck drug (if authorized), 500K+ of AZN preventive antibody, 300K of Vir/GSK antibody' Benzinga

05:38AM EST U.S. Equity Futures Lower, European Markets Mixed; Governments Across the World Tighten Restrictions Due to Omicron Surge; Tech Companies Cancel Out of CES Vegas Event Benzinga

Dec 21, 2021

03:36PM EST 'Majority in the Immunization Committee in Israel votes for the provision of a fourth vaccine dose to at-risk groups - vaccine-suppressed, adults over the age of 60 and health care workers.' -Israel Reporter Tweet Benzinga

10:24AM EST NYC Mayor's Office Tweets '@NYCMayor just announced a new $100 incentive for New Yorkers if they get their booster shot at City-run sites before December 31.' Benzinga

04:36AM EST AstraZeneca Announced Ultomiris Regulatory Submission Accepted under FDA Priority Review in the US for Adults with Generalized Myasthenia Gravis Benzinga

Dec 20, 2021

11:34AM EST WHO's Chief Scientist Says 'Very Dangerous' To Jump To Conclusion That All Vaccines, Except mRNA Shots, Are Not Working Against Omicron Variant Benzinga

05:28AM EST U.S. Equity Futures, European Markets Fall Sharply Over Rising Omicron Concerns; Two U.S. Senators Test Positive for Covid-19; Moderna Said Booster Effective vs Omicron; Senator Manchin Says he Will Not Support Biden Spending Bill Benzinga

05:20AM EST AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma Benzinga

04:45AM EST AstraZeneca Announced Saphnelo Recommended for Approval in the EU by CHMP for the Treatment of Patients with Systemic Lupus Erythematosus Benzinga

04:44AM EST AstraZeneca Announced Tezspire Approved in the US for Severe Asthma Benzinga

Dec 19, 2021

07:20PM EST New Jersey Democratic Senator Cory Booker Says He Has Tested Positive for Covid-19 Benzinga

05:16PM EST Massachusetts Senator Warren Tests Positive for Covid-19 Benzinga

12:54PM EST The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week Benzinga

Dec 16, 2021

01:57PM EST World Trade Organization Chief Says Parties Getting Close To Solution In Dispute Over COVID-19 Vaccine Rights Benzinga

01:27PM EST AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant Benzinga

10:02AM EST AstraZeneca's EVUSHELD Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant : New Preclinical Data RTTNews

09:58AM EST EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in independent FDA study Business Wire

09:11AM EST AstraZeneca Says Evusheld 'retained neutralising activity against the Omicron SARS-CoV-2 variant' Benzinga

05:53AM EST Odyssey Acquisition Announced BenevolentAI Achieves Second Major Collaboration Milestone With Novel Idiopathic Pulmonary Fibrosis Target Selected for AstraZeneca's Portfolio Benzinga

Dec 15, 2021

11:13AM EST Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back Benzinga

05:01AM EST Transgene Announced License Option Exercise by AstraZeneca for Oncolytic Virus Generated by Transgene's Invir.IO Platform Benzinga

01:37AM EST Transgene : License Option Exercise By AstraZeneca For Oncolytic Virus Generated By Transgene's Invir.IO Platform RTTNews

Dec 14, 2021

11:27AM EST World Health Organization Chief Tedros Says People Are Wrong To Consider Omicron Variant As Causing Mild Disease, That Sentiment Could Overwhelm Unprepared Health Systems Benzinga

10:16AM EST NFL Mandates Booster Shots Among Team Staff Benzinga

08:22AM EST The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks Benzinga

08:12AM EST Samsung Biologics, AstraZeneca Expand Collaboration To Include COVID-19, Cancer Therapy Benzinga

04:49AM EST Samsung Biologics and AstraZeneca Announced Expanded Strategic Manufacturing Partnership to Include COVID-19 and Cancer Therapy Benzinga

Dec 13, 2021

08:05PM EST Samsung Biologics, AstraZeneca Expand Strategic Manufacturing Partnership To Include COVID-19 And Cancer Therapy RTTNews

07:56PM EST Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to PR Newswire

11:24AM EST UK Reports First Omicron Death, PM Johnson Encourages Boosters Benzinga

05:12AM EST University of Oxford Study Shows Two-dose Covid-19 Vaccine Regimens Do Not Induce Enough Neutralizing Antibodies vs Omicron Coronavirus Variant Benzinga

Dec 12, 2021

04:56PM EST The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More Benzinga

10:00AM EST CALQUENCE reduced the risk of disease progression or death by 71% vs. standard of care combinations at three years in the ASCEND Phase III trial Business Wire

Dec 10, 2021

12:46PM EST AstraZeneca's Dapagliflozin No Longer Authorized For Type 1 Diabetes In UK Benzinga

11:43AM EST UK Health Security Agency Says Booster Increases Protection Against Mild COVID Disease To Around 70%-75% In Real World Study Looking At 581 People With Confirmed Omicron Variant Benzinga

06:40AM EST AstraZeneca Shares Lower After UK's Medicines & Healthcare Products Regulatory Agency Says Dapagliflozin No Longer Authorized For Treatment Of Type 1 Diabetes Mellitus Benzinga

Dec 9, 2021

09:56PM EST 'Gov. Kathy Hochul said she will announce new policies tomorrow as more cases of the Omicron variant are confirmed in New York.' -CBS New York Benzinga

09:49PM EST AstraZeneca Highlights Presentation Of ENHERTU Analyses At SABCS 2021 Benzinga

09:47PM EST AstraZeneca's COVID-19 Therapy Wins FDA Approval As First Antibody To Prevent Infection In Immunocompromised Benzinga

09:46PM EST The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO Benzinga

09:42PM EST 'Senate votes to repeal key Biden administration vaccine and testing policy' -Earlier Washington Post Report Benzinga

09:38PM EST UPDATE: FDA Says Issued Emergency Use Authorization For AstraZeneca's EvuShield For Pre-Exposure Prevention Of COVID-19 In Certain Individuals Benzinga

09:38PM EST AstraZeneca Shares Quiet Following Report FDA Authorized New Long-Acting Monoclonal Antibodies For Pre-Exposure Prevention Of COVID-19 In Certain Individuals Benzinga

10:05AM EST ENHERTU(r) (fam-trastuzumab deruxtecan-nxki) Additional Analyses Further Reinforce Ground-breaking Efficacy in Patients With HER2-positive Metastatic Breast Cancer Business Wire

02:13AM EST AstraZeneca's Evusheld Gets Emergency Use Authorisation In The US For Pre-exposure Prophylaxis (prevention) Of COVID-19 RTTNews

Dec 8, 2021

07:56PM EST AstraZeneca's EVUSHELD Antibody Combination Authorized For Emergency Use In US For Pre-exposure Prophylaxis Of COVID-19 RTTNews

07:37PM EST EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19 Business Wire

11:13AM EST AstraZeneca's EVUSheld Authorized For COVID Prevention Benzinga

Dec 7, 2021

01:03PM EST Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response Benzinga

10:18AM EST Daiichi Sankyo Reports Co. Development Program With AstraZeneca, Datopotamab Deruxtecan Continues To Show Durable Response, Disease Control In Patients with Metastatic Triple Negative Breast Cancer Benzinga

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021 Benzinga

08:26AM EST The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Dar Benzinga

07:44AM EST Ionis, AstraZeneca Ink Licensing Pact For Eplontersen In Protein Misfolding Disorder Benzinga

06:11AM EST A Peek Into The Markets: US Stock Futures Higher Following Monday's Rally Benzinga

05:05AM EST Jefferies Downgrades AstraZeneca to Hold Benzinga

04:41AM EST Ionis Announced Collaboration With AstraZeneca to Develop and Commercialize Eplontersen; Ionis to Receive $200M Upfront, Up to $485M in Development and Approval Milestones, Up to $2.9B in Sales-related Milestone Payments Benzinga

Dec 6, 2021

01:50PM EST CNN Reporter Tweets 'Good news on Omicron and vaccines: "The early indication is that you are going to be protected against serious illness with two doses of mRNA-containing vaccines. And the booster dose can increase antibodies,"' Benzinga

10:27AM EST UPDATE: Children Aged 5-11 Required To have At Least 1 COVID Vaccine Shot For Indoor Activities Starting Dec. 14 Benzinga

08:09AM EST Johnson & Johnson Booster COVID-19 Shot Shows Encouraging Action After Pfizer/BioNTech Jab Benzinga

Dec 5, 2021

09:15AM EST CDC Director Walensky Said Omicron Covid-19 Cases Found in at Least 15 U.S. States; Said Delta Variant of Covid-19 Still Makes Up Majority of U.S. Cases Benzinga

Dec 3, 2021

10:30AM EST AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer Care Business Wire

07:10AM EST AstraZeneca :data To Reinforce Practice-changing Potential Of ENHERTU With Analyses From DESTINY-Breast03 Trial RTTNews

07:00AM EST AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer Care Business Wire

06:50AM EST AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report Benzinga

05:07AM EST AstraZeneca Blocked $7.6B Takeover of Swedish Orphan Biovitrum AB by Withholding its 8% Stake in Drugmaker from a Buyout offer by Advent International and Singapore Wealth fund GIC Benzinga

04:53AM EST AstraZeneca Announced Data From Destiny-Breast03 Will Reaffirm Efficacy Of Enhertu Benzinga

04:52AM EST India's Health Ministry Said India's Serum Institute Raises AstraZeneca COVID-19 Vaccine Monthly Production Capacity to 250M-275M Doses Benzinga

Dec 2, 2021

01:53PM EST President Biden Says Team Is Working With Vaccine Firms For Contingency Plan For Vaccines, Boosters Benzinga

12:48PM EST Possible New Links Identified With AstraZeneca COVID-19 Shot, Blood Clots Benzinga

04:56AM EST Possible New Links Between AstraZeneca Vaccine and Blood Clots Found Benzinga

Dec 1, 2021

12:03PM EST Former German PM Merkel Proposes Mandatory COVID Shots Starting Feb. 2022 Benzinga

09:42AM EST European Medicines Agency Has Approved A New Site To Manufacture AstraZeneca's Vaxzevria COVID-19 Vaccine Finished Product Benzinga

07:18AM EST WHO Official Says Some of the Early Indications Is That Most Omicron Cases Are Mild, No Severe Cases Benzinga

05:45AM EST Norway Detected First Two Cases of Omicron Covid Variant Benzinga

05:11AM EST Japan Confirmed Second Case of Omicron Variant of the Covid-19 on Wednesday Benzinga

05:00AM EST Israel's Health Minister Nitzan Horowitz Said Individuals Fully Vaccinated Against Corona Within Six Months or With the Booster are Protected Against the Omicron Variant Benzinga

Nov 30, 2021

04:47PM EST The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout Benzinga

04:44PM EST AstraZeneca-Merck's Lynparza Under FDA Priority Review For Breast Cancer Setting Benzinga

04:42PM EST AstraZeneca And Merck Announce FDA Has Accepted Submission Of Supplemental New Drug Application For LYNPARZA Benzinga

04:42PM EST Two Israeli Doctors Infected with Omicron Variant Benzinga

04:40PM EST China Xinhua News Says No Omicron Cases Reported on Chinese Mainland So Far Benzinga

04:39PM EST U.S. Equity Futures, European Markets Fall Following Moderna CEO Comments on Vaccines Likely Less Effectiveness Against Omicron Variant Benzinga

04:39PM EST Dutch Authorities Said Omicron Variant Was Detected in the Netherlands on Nov. 19, Before S. Africa Flights Benzinga

04:39PM EST Genetron Health Announced Late Monday, A Co-Development Agreement with AstraZeneca R&D China for Personalized MRD Tests for Solid Tumors in China Benzinga

04:39PM EST Moderna CEO Said in Financial Times Interview Vaccines are Likely Less Effective against Omicron; Said Mutations Mean Existing Vaccines Likely Need Modifying Benzinga

06:30AM EST LYNPARZA(r) (olaparib) Granted Priority Review in the US for BRCA-Mutated HER2-Negative High-Risk Early Breast Cancer Business Wire

02:05AM EST AstraZeneca's Lynparza SNDA Granted Priority Review In US For BRCA-mutated HER2-negative High-risk Early Breast Cancer RTTNews

Nov 29, 2021

10:00PM EST Genetron Health Announces Co-Development Agreement with GlobeNewswire Inc

06:26AM EST World Health Organization Tweeted Earlier "We don't yet know whether Omicron is associated with more: -transmission -severe #COVID19 disease -risk of reinfections -risk of evading vaccines. Scientists at WHO & around the Benzinga

05:58AM EST Italy's Radiocor Says Italy Reported Four Omicron Variant Cases Benzinga

Nov 28, 2021

05:07PM EST NIH Director Collins Said Current Vaccinations Likely to Protect Against Omicron Benzinga

09:14AM EST National Institute of Allergy and Infectious Diseases Director Fauci Tells ABC News Too Early to Say if We Need New Lockdowns or Mandates Benzinga

Nov 27, 2021

09:23AM EST Two cases of Omicron Variant Detected in UK: Individuals in Chelmsford and Nottingham had Traveled to Southern Africa Benzinga

Nov 26, 2021

05:43AM EST France, Czech Republic, Singapore Among Countries Reported to Restrict Travel from Southern Africa Due to "Nu" Variant Benzinga

05:15AM EST Total of 84 Confirmed Cases of COVID-19 Variant B.1.1.529 With 77 in S. Africa, 4 in Botswana, 2 in Hong Kong, 1 in Israel Benzinga

05:12AM EST U.S. Equity Futures Sharply Lower; Covid-Related Stocks Surge on Reports of New, Heavily-Mutated Strain, Feared to be More Infectious than Delta Variant Benzinga

05:09AM EST Israeli, Who Returned from Malawi, Tested Positive for New Highly-Mutated Covid-19 Strain Reported in S. Africa Benzinga

Nov 24, 2021

06:44AM EST World Health Organization Issues Interim Statement on Covid-19 Vaccination for Children and Adolescents, Says They Have Lower Risk of Severe Disease Benzinga

Nov 23, 2021

07:00PM EST Follows important findings from the TATTON1 study of the combination in EGFR inhibitor refractory lung cancer patients whose tumors harbor aberrations of MET GlobeNewswire Inc

05:03PM EST 'AstraZeneca vaccine may give longer protection that is shielding UK from new Covid wave' -The Telegraph Report Benzinga

02:16PM EST Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst Benzinga

Nov 22, 2021

12:41PM EST EU Says Decision On J&J COVID-19 Booster Shot Expected 'Within Weeks' Benzinga

Nov 19, 2021

09:55AM EST Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations PR Newswire

Nov 18, 2021

10:00AM EST EU Drug Regulator EMA Says Most Likely Beginning Of Next Year Will Proceed 'Rapidly' Towards Conclusion Of Approval For AstraZeneca COVID Antibody Drug Benzinga

09:06AM EST AstraZeneca CEO Soriot Says Main Use Of Antibody Cocktail Would Be To Prevent COVID-19 And Offer More Protection For People Who Don't Respond To Vaccines Benzinga

08:06AM EST AstraZeneca And Daiichi Sankyo Company Announce The First Patient Was Dosed In The Global TROPION-Breast01 Phase 3 Trial Evaluating The Efficacy And Safety Of Datopotamab Deruxtecan Benzinga

07:55AM EST The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings Benzinga

07:24AM EST AstraZeneca's COVID-19 Antibody Shows 83% Protection Over Six Months Benzinga

07:00AM EST New Analyses of Two AZD7442 COVID-19 Phase III Trials in High-Risk Populations Confirm Robust Efficacy and Long-Term Prevention Business Wire

05:03AM EST AstraZeneca Says Trial Data Shows Its Treatment Cuts Risk of Symptomatic COVID-19 By 83% Benzinga

Nov 17, 2021

10:10AM EST AZN:LOKELMA Granted Fast Track Designation In US To Reduce Cardiovascular Outcomes On Chronic Hemodialysis With HK RTTNews

10:04AM EST AstraZeneca's LOKELMA Granted Fast Track Designation In U.S. To Reduce Cardiovascular Outcomes In Patients On Chronic Hemodialysis With Hyperkalemia Benzinga

10:03AM EST LOKELMA(r) Granted Fast Track Designation in the US to Reduce Cardiovascular Outcomes in Patients on Chronic Hemodialysis With Hyperkalemia Business Wire

Nov 15, 2021

02:38PM EST AstraZeneca, Moderna Shares Early Cut Data For mRNA Candidate In Heart Failure Benzinga

10:52AM EST Moderna Posts Interim Data From mRNA Triplet Program In Solid Tumors Benzinga

Nov 12, 2021

03:12PM EST Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop Benzinga

12:17PM EST Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet Benzinga

10:14AM EST Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter Benzinga

08:10AM EST Recap: AstraZeneca Q3 Earnings Benzinga

07:47AM EST The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares Benzinga

06:02AM EST AstraZeneca's COVID-19 Vaccine Turns Profitable In Q3; Reaffirms FY21 Guidance Benzinga

05:51AM EST A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Consumer Sentiment Report Benzinga

05:09AM EST AstraZeneca PLC Q3 Adj EPS $1.08 Beat $0.62 Est; Revenue $9.87B Inline With Est Benzinga

04:26AM EST Earnings Scheduled For November 12, 2021 Benzinga

Nov 11, 2021

08:36AM EST International companies to host live webcasts at Deutsche Bank's Depositary PR Newswire

Nov 10, 2021

06:56AM EST AstraZeneca Plans To Set Up Separate Division For Vaccines & Antibody Therapies - Report Benzinga

Nov 9, 2021

12:01PM EST AstraZeneca Is Creating A Dedicated Vaccines And Immune Therapies Unit, Team Will Be Led By Iskra Reic, A Senior Executive Benzinga

11:25AM EST AstraZeneca's COVID-19 Antibody Cocktail Clears First Step for Registration in Australia Benzinga

Nov 8, 2021

08:29AM EST The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More Benzinga

05:04AM EST AstraZeneca Says New Sub-Analyses Further Support Consistency Of Farxiga'S Cardiorenal And Mortality Benefits In Treating Chronic Kidney Disease Benzinga

05:01AM EST AstraZeneca Says Fasenra Granted Orphan Drug and Fast Track Designations by the FDA For Eosinophilic Gastritis And Eosinophilic Gastroenteritis Benzinga

Nov 5, 2021

09:36AM EDT AstraZeneca Announced Calquence Shows Durable Efficacy and Favourable Tolerability vs Standards of Care Across Multiple Analyses in Chronic Lymphocytic Leukaemia Benzinga

07:00AM EDT AstraZeneca Advances Ambition to Redefine Care for Blood Cancer at ASH 2021 Business Wire

Nov 3, 2021

10:11AM EDT PhaseBio's Bentracimab Reverses Ticagrelor-Associated Antiplatelet Activity In Mid-Stage Study Benzinga

09:17AM EDT Integral Molecular Enters Into Antibody License Agreement With AstraZeneca For Oncology Therapeutics Benzinga

08:06AM EDT Integral Molecular Reaches Antibody License Agreement With AstraZeneca For Oncology Therapeutics RTTNews

08:03AM EDT Integral Molecular Enters into Antibody License Agreement with AstraZeneca for PR Newswire

Nov 2, 2021

10:52AM EDT SAGA Diagnostics Reports Assay Development Deal With AstraZeneca, No Terms Disclosed Benzinga

Nov 1, 2021

11:08AM EDT SAPHNELO Consistently Reduces Systemic Lupus Erythematosus Disease Activity Regardless of Disease Duration and Prior Treatment Business Wire

07:41AM EDT AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio Benzinga

07:00AM EDT AstraZeneca Awards 30 Nonprofit Organizations through the ACT on Health Equity Community Solutions Challenge to Actively Address Health Disparities Business Wire

06:16AM EDT AstraZeneca To Offload Some Drug Rights To Covis Pharma For $270M Benzinga

04:54AM EDT HUTCHMED, AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI in Patients with MET-Driven Advanced Papillary Renal Cell Carcinoma Benzinga

04:50AM EDT AstraZeneca to Transfer Global Rights for Eklira and Duaklir to Covis Pharma for $270M Benzinga

Oct 28, 2021

02:50PM EDT White House Says Decisions On Vaccine Intellectual Property Waivers Will Not occur At G20 But At Coming Trade Meeting Benzinga

12:20PM EDT Millions Of JNJ COVID-19 Shots Sit Idle At Emergent's Baltimore Plant: Reuters Benzinga

Oct 26, 2021

08:36AM EDT The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children Benzinga

08:07AM EDT AstraZeneca's Imfinzi/Chemo Combo Strikes First Immunotherapy Wins In Bile Duct Cancer Trial Benzinga

Oct 25, 2021

04:25PM EDT AstraZeneca Announces High-Level Results From TOPAZ-1 Phase III Trial Of IMFINZI In Combination With Standard-Of-Care Chemotherapy; Says Independent Data Monitoring Committee Concluded Trial Met Primary Endpoint Benzinga

04:21PM EDT IMFINZI Plus Chemotherapy Significantly Improved Overall Survival in 1st-Line Advanced Biliary Tract Cancer in TOPAZ-1 Phase III Trial at Interim Analysis Business Wire

08:23AM EDT AstraZeneca Says Second Clinical Trial Collaboration Initiated To Evaluate Datopotamab Deruxtecan In Combination With KETRUDA In Patients With Metastatic Non-Small Cell Lung Cancer Benzinga

02:07AM EDT AstraZeneca Reports Positive High-level Results From TOPAZ-1 Phase 3 Trial In 1st-line Advanced Biliary Tract Cancer RTTNews

Oct 21, 2021

12:10PM EDT AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial Benzinga

Oct 20, 2021

09:00AM EDT AstraZeneca Announces Winners and Recognizes Oncology Change Makers in Third Annual Cancer Community Awards Business Wire

05:03AM EDT Oxford Vaccine Head Said Delta Subvariant Unlikely to Change Covid Situation Dramatically Benzinga

Oct 19, 2021

05:46AM EDT AstraZeneca, Unilever Tumble As FTSE 100 Struggles With Rising Energy Prices Benzinga

Oct 18, 2021

10:14AM EDT Earnings Season Continues with State Street, Albertsons, and Sandvik Announcing on Monday Morning Benzinga

Oct 15, 2021

03:04PM EDT AstraZeneca Wins Ruling Upholding Farziga Patent Benzinga

07:44AM EDT The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO Benzinga

07:00AM EDT IMFINZI Plus Tremelimumab Significantly Improved Overall Survival in HIMALAYA Phase III Trial in 1st-Line Unresectable Liver Cancer Business Wire

05:09AM EDT AstraZeneca Announced Himalaya Phase III Trial Met Primary Endpoint of Survival in 1st-line Unresectable Liver Cancer Benzinga

Oct 13, 2021

05:11AM EDT AstraZeneca Covid-19 Vaccine Will No Longer Be Made in Australia Due to Demand for Pfizer, Moderna Vaccines Benzinga

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 11, 2021

01:33PM EDT AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial Benzinga

09:05AM EDT AstraZeneca's Global Product Lead Says Co. In Talks With Regulators About Pediatric Study For COVID-19 Treatment, Hope To Begin Early In 2022 Benzinga

06:36AM EDT 'Russian spies 'stole formula for Oxford/Astra Zeneca Covid jab and used it to create Sputnik vaccine'' - The Sun Benzinga

05:09AM EDT AstraZeneca Announced AZD7442 Reduced Risk of Developing Severe Covid-19 or Death in TACKLE Phase III Outpatient Treatment Trial; Trial Met Primary Endpoint Benzinga

01:35AM EDT Why New COVID-19 Vaccination-Related Rules In This Australian State Have Small Businesses Worried Benzinga

Oct 8, 2021

07:05AM EDT AstraZeneca: FDA Grants Orphan Drug Designation For Tezepelumab In The US For Eosinophilic Esophagitis RTTNews

07:00AM EDT AstraZeneca Reports Tezepelumab Granted Orphan Drug Designation In US For Eosinophilic Esophagitis Benzinga

07:00AM EDT Tezepelumab granted Orphan Drug Designation in the US for eosinophilic esophagitis Business Wire

Oct 7, 2021

09:59AM EDT AstraZeneca's Debt Overview Benzinga

09:46AM EDT WHO's Tedros Says There Is Enough Vaccine Supply To Reach 40% Of World By End Of 2021, 70% By Mid 2022 If 'Distributed Equitably' Benzinga

09:37AM EDT AstraZeneca Granted Orphan Designation For Tezepelumab Benzinga

Oct 6, 2021

12:12PM EDT White House Advisor Dr. Fauci Says Merck's COVID-19 Pill Does Not Remove The Need For A Vaccine Benzinga

11:04AM EDT Best Crypto PR Agencies You Must Know Benzinga

Oct 5, 2021

08:31AM EDT AstraZeneca Seeks Emergency Use Nod For COVID-19 Drug To Prevent Infection Benzinga

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

07:00AM EDT AZD7442 Request for Emergency Use Authorization for COVID-19 Prophylaxis Filed in US Business Wire

04:56AM EDT Astrazeneca Submitted Request to FDA Emergency Use Authorization for AZD7442 for Prophylaxis of Symptomatic Covid-19 Benzinga

Oct 4, 2021

07:06AM EDT Compugen To Receive $6 Mln Milestone Payment From AstraZeneca RTTNews

07:03AM EDT Compugen Receives $6M Milestone Payment From AstraZeneca Triggered By First Patient Dosed With TIGIT Bispecific Derived From COM902 Benzinga

07:01AM EDT Compugen Announces Milestone Payment from AstraZeneca Triggered by First PR Newswire

07:00AM EDT ENHERTU(r) (fam-trastuzumab deruxtecan-nxki) Granted Breakthrough Therapy Designation in US for Patients with HER2-Positive Metastatic Breast Cancer Treated with One or More Prior Anti-HER2-Based Regimens Business Wire

05:13AM EDT AstraZeneca Announced Enhertu Granted FDA Breakthrough Therapy Designation for Breast Cancer Benzinga

Oct 1, 2021

09:06AM EDT EMA's Risk Assessment Committee Finds Link Of Rare Cases Between JNJ COVID-19 Shot, Blood Clots Benzinga

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 30, 2021

03:16PM EDT AstraZeneca COVID-19 Jab Shows 74% Efficacy In US Trial Benzinga

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 29, 2021

04:36PM EDT NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC Benzinga

02:28PM EDT Why AstraZeneca And Pfizer Shares Are Moving Today Benzinga

08:13AM EDT The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug Benzinga

07:07AM EDT Fortress Biotech Announces Receipt Of Notice Of Option Exercise From AstraZeneca To Fully Acquire Caelum Biosciences, A Company Founded By Fortress Biotech; Option Triggers Upfront Payment Of $150M To Caelum, Of Which $64M Is Payable To Fortress Benzinga

07:00AM EDT AstraZeneca Healthcare Foundation Awards Seven US Nonprofits More Than $900k to Improve Heart Health and Advance Health Equity Business Wire

05:06AM EDT AstraZeneca's Alexion has Exercised its Option to Acquire all Remaining Equity in Caelum Biosciences for $150M Plus Up tp $350M in Milestone Payments Benzinga

Sep 28, 2021

11:03AM EDT 'AstraZeneca to develop vaccine for treating cancer and heart conditions' -Earlier Business Insider India Article Benzinga